SHS News Current page: 3

In the course of a successful succession arrangement, Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH sells its shares in medigroba GmbH to Löwenstein Group With SHS as majority shareholder, medigroba has more than doubled revenue and tripled EBITDA in the last four and a half years Due to the continuing trend towards outpatient care, the medium-sized […]

Tübingen-based healthcare investor SHS has provided capital and expertise to Crystal Laser Systems GmbH (CryLaS) on its way to becoming a leading, profitable provider of laser technology and is handing over the baton to Silver Investment Partners SIP CryLaS enjoys an excellent reputation worldwide in the healthcare, biotech and semiconductor sectors with pulsed and CW […]

SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) has sold its shares in the Austrian life science supplier Single Use Support GmbH (SUS) to Pall Corporation. SUS sets new standards for the transport of liquid substances in the medtech industry with its products, a success story Life science, biotech, pharmaceutical and medical device companies worldwide now use […]

The Tübingen-based medtech investor SHS is investing in Blue Ocean Spine GmbH, a developer for 3D-printed spinal implants Blue Ocean Spine is developing a portfolio of new spinal implants that can be precisely adapted to patient needs in situ or administered without additional means of fixation such as screws For Guntmar Eisen, a serial entrepreneur […]

Tübingen-based industry investor SHS acquires minority share in formulation specialist Develco Pharma Develco specializes in the development, approval and production of innovative and generic specialty drugs and offers a unique and broad set of formulation technologies for orally administered medicines with specific substance-release profiles Develco operates a state-of-the-art production facility of its own in Germany […]

SHS Gesellschaft für Beteiligungsmanagement mbH, based in Tübingen, is selling its shares in puracon GmbH to Klingel medical metal GmbH, a portfolio company of IK Investment Partners. With 600 employees, Klingel Group is one of the leading companies in the field of precision machining of high-strength materials such as stainless steel and titanium for the […]

Effective October 1, 2020, Tübingen-based medtech investor SHS has appointed Prof. Marc O. Schurr, founder and Executive Board member of Ovesco AG, as Senior Advisor Schurr, a successful medtech entrepreneur and professor of experimental medicine and medical technology, understands what matters when it comes to clinical approvals and regulatory processes In Schurr, SHS gains a […]

Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine Series A led by new investors Panakès Partners, INKEF Capital and SHS Gesellschaft für Beteiligungsmanagement Eindhoven, the Netherlands, September 22, 2020 – Salvia BioElectronics B.V., a neurostimulation platform company targeting chronic migraine, today announced it has raised EUR 26M in […]

SHS sees medical technology back on track for success in Germany in 2019 Medical technology sector increases turnover by 10% in 2019 In spite of COVID-19, SHS expects the medical technology industry to outperform the German economy as a whole in 2020 as well Effects of the EU Medical Device Regulation (MDR) not yet digested […]

Heinz Jacqui (59) has been appointed Senior Advisor at SHS Gesellschaft für Beteiligungsmanagement effective June 1, 2020. By way of succession arrangements or growth financing, SHS specializes in investing in innovative healthcare companies that focus on medical technology and the life sciences. Through several funds, SHS has more than EUR 300 million under management. It […]

The M&A consultancy Clairfield and Luther Rechtsanwaltsgesellschaft prepared this informative study with the support of the German Medical Technology Association (BVMed) and the German Engineering Federation (VDMA). The study gives you an overview of the current development of medical technology in Germany, Europe, the USA and Asia: from a legal, technical and transaction-oriented perspective. Due […]

On April 1, 2020, Sascha Alilovic (46) was appointed Managing Partner of SHS Gesellschaft für Beteiligungsmanagement. Whether by way of succession arrangements or growth financing, SHS specializes in investing in innovative healthcare companies with a focus on medical technology and life sciences. Through several funds, SHS has more than EUR 300 million under management. It […]